Death, Sudden, Cardiac
0
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
StrykerECMO resuscitation
MedtronicMedtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)
MedtronicDefibrillator, Dual Chamber ; Implantable
Clinical Trials (3)
Total enrollment: 2,251 patients across 3 trials
Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 )
Start: Sep 2019Est. completion: Dec 20225 patients
N/ACompleted
Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)
Start: Apr 2008Est. completion: May 20091,023 patients
N/ACompleted
DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.
Start: Feb 2007Est. completion: Dec 20121,223 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.